Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
Creator
Wang, Hua
Li, Yangyang
Shi, Xuanling
Wang, Han
Zhou, Panpan
Zhou, Tongqing
Fang, Mengqi
Li, Zihao
Shang, Hong
Shi, Shasha
Wu, Jiapeng
Hanid, Xiaoxu
Zhangid, Linqi
topic
covid:57eb57853f082c4b343cb136c248c9b14f5e632c#this
source
PMC
abstract
Recently identified broadly neutralizing antibodies (bnAbs) show great potential for clinical interventions against HIV-1 infection. However, resistant strains may impose substantial challenges. Here, we report on the identification and characterization of a panel of HIV-1 strains with broad and potent resistance against a large number of bnAbs, particularly those targeting the CD4-binding site (CD4bs). Site-directed mutagenesis revealed that several key epitope mutations facilitate resistance and are located in the inner domain, loop D, and β23/loop V5/β24 of HIV-1 gp120. The resistance is largely correlated with binding affinity of antibodies to the envelope trimers expressed on the cell surface. Our results therefore demonstrate the existence of broadly resistant HIV-1 strains against CD4bs neutralizing antibodies. Treatment strategies based on the CD4bs bnAbs must overcome such resistance to achieve optimal clinical outcomes.
has issue date
2019-06-13
(
xsd:dateTime
)
bibo:doi
10.1371/journal.ppat.1007819
bibo:pmid
31194843
has license
cc0
sha1sum (hex)
57eb57853f082c4b343cb136c248c9b14f5e632c
schema:url
https://doi.org/10.1371/journal.ppat.1007819
resource representing a document's title
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
has PubMed Central identifier
PMC6592578
has PubMed identifier
31194843
schema:publication
PLoS Pathog
resource representing a document's body
covid:57eb57853f082c4b343cb136c248c9b14f5e632c#body_text
is
http://vocab.deri.ie/void#inDataset
of
proxy:http/ns.inria.fr/covid19/57eb57853f082c4b343cb136c248c9b14f5e632c
is
schema:about
of
named entity 'NEUTRALIZING ANTIBODIES'
named entity 'strains'
named entity 'CD4'
named entity 'neutralizing antibodies'
named entity 'RESISTANT'
named entity 'HIV-1'
named entity 'OPTIMAL'
named entity 'CD4'
named entity 'HIV-1'
named entity 'CHARACTERIZATION'
named entity 'GREAT'
named entity 'NEUTRALIZING ANTIBODIES'
named entity 'BROADLY NEUTRALIZING ANTIBODIES'
named entity 'IDENTIFIED'
named entity 'ANTIBODIES'
named entity 'RESISTANCE'
named entity 'MUTATIONS'
named entity 'PANEL'
named entity 'LARGE'
named entity 'STRATEGIES'
named entity 'EPITOPE'
named entity 'BINDING SITE'
named entity 'NUMBER OF'
named entity 'TREATMENT'
named entity 'OUR'
covid:arg/57eb57853f082c4b343cb136c248c9b14f5e632c
named entity 'BASED'
named entity 'CORRELATED'
named entity 'CD4'
named entity 'THE CELL'
named entity 'OVERCOME'
named entity 'KEY'
named entity 'LOCATED IN'
named entity 'BINDING AFFINITY'
named entity 'GP120'
named entity 'HERE'
named entity 'RESISTANCE TO'
named entity 'IDENTIFICATION'
named entity 'POTENTIAL'
named entity 'CLINICAL OUTCOMES'
named entity 'SITE-DIRECTED MUTAGENESIS'
named entity 'RESULTS'
named entity 'HIV-1 INFECTION'
named entity 'REPORT'
named entity 'TARGETING'
named entity 'BROAD'
named entity 'RESISTANT'
named entity 'BINDING SITE'
named entity 'RECENTLY'
named entity 'STRAINS'
named entity 'EXPRESSED'
named entity 'CHALLENGES'
named entity 'CELL SURFACE'
named entity 'INNER'
named entity 'IMPOSE'
named entity 'LOOP'
named entity 'DOMAIN'
named entity 'ENVELOPE'
named entity 'REVEALED'
named entity 'CLINICAL INTERVENTIONS'
named entity 'antibodies'
named entity 'trimers'
named entity 'strains'
named entity 'correlated'
named entity 'CD4'
named entity 'substantial'
named entity 'resistant'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 8
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software